You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 13, 2024

Investigational Drug Information for Emodepside


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Emodepside?

Emodepside is an investigational drug.

There have been 6 clinical trials for Emodepside. The most recent clinical trial was a Phase 1 trial, which was initiated on August 15th 2021.

The most common disease conditions in clinical trials are Ancylostomiasis, Filariasis, and Hookworm Infections. The leading clinical trial sponsors are Bayer, Drugs for Neglected Diseases, and Bill and Melinda Gates Foundation.

There are one hundred and thirty-seven US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Emodepside
TitleSponsorPhase
Efficacy and Safety of Emodepside in Adults Infected With HookwormPublic Health Laboratory Ivo de CarneriPhase 2
Efficacy and Safety of Emodepside in Adults Infected With HookwormJennifer KeiserPhase 2
Emodepside Phase II Trial for Treatment of OnchocerciasisBayerPhase 2

See all Emodepside clinical trials

Clinical Trial Summary for Emodepside

Top disease conditions for Emodepside
Top clinical trial sponsors for Emodepside

See all Emodepside clinical trials

US Patents for Emodepside

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Emodepside ⤷  Try a Trial Six-membered C--N-bonded aryl sulphide and aryl sulphoxide derivatives as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE) ⤷  Try a Trial
Emodepside ⤷  Try a Trial Anthelmintic compounds MERIAL INC. (Duluth, GA) ⤷  Try a Trial
Emodepside ⤷  Try a Trial Pyrazolopyridine sulfonamides as nematicides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE) ⤷  Try a Trial
Emodepside ⤷  Try a Trial Anthelmintic depsipeptide compounds MERIAL, INC. (Duluth, GA) ⤷  Try a Trial
Emodepside ⤷  Try a Trial 2-(het)aryl-substituted fused bicyclic heterocycle derivatives as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE) ⤷  Try a Trial
Emodepside ⤷  Try a Trial Substituted guanidines as fungicides Nippon Soda Co., Ltd. (Tokyo, JP) ⤷  Try a Trial
Emodepside ⤷  Try a Trial Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Emodepside

Drugname Country Document Number Estimated Expiration Related US Patent
Emodepside Australia AU2015286634 2034-07-11 ⤷  Try a Trial
Emodepside Brazil BR112017000398 2034-07-11 ⤷  Try a Trial
Emodepside China CN106659720 2034-07-11 ⤷  Try a Trial
Emodepside European Patent Office EP3177291 2034-07-11 ⤷  Try a Trial
Emodepside Japan JP2017519802 2034-07-11 ⤷  Try a Trial
Emodepside World Intellectual Property Organization (WIPO) WO2016005576 2034-07-11 ⤷  Try a Trial
Emodepside Brazil BR112017002359 2034-08-13 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.